Nanobac Pharmaceuticals, Incorporated (NNBP)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Aug 17, 2026
Nanobac Pharmaceuticals Revenue
In the year 2007, Nanobac Pharmaceuticals had annual revenue of $17.62K, down -92.17%. Nanobac Pharmaceuticals had revenue of $4.37K in the quarter ending December 31, 2007, with 86.59% growth.
Revenue
17.62K
Revenue Growth
-92.17%
P/S Ratio
0.01
Revenue / Employee
17.62K
Employees
1
Market Cap
250.00
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2007 | 17.62K | -207.47K | -92.17% |
| Dec 31, 2006 | 225.09K | -431.72K | -65.73% |
| Dec 31, 2005 | 656.80K | 298.44K | 83.28% |
| Dec 31, 2004 | 358.36K | -124.45K | -25.78% |
| Dec 31, 2003 | 482.82K | - | - |
| Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Statera Biopharma | 3.69M |
| Scorpius Holdings | 1.72M |
| GeneLink | 1.58M |
| Health Sciences Group | 69.31K |
| NanoLogix | 1.27K |